MX2015011394A - Condon. - Google Patents

Condon.

Info

Publication number
MX2015011394A
MX2015011394A MX2015011394A MX2015011394A MX2015011394A MX 2015011394 A MX2015011394 A MX 2015011394A MX 2015011394 A MX2015011394 A MX 2015011394A MX 2015011394 A MX2015011394 A MX 2015011394A MX 2015011394 A MX2015011394 A MX 2015011394A
Authority
MX
Mexico
Prior art keywords
condom
condoms
water
neutralising
physiologically
Prior art date
Application number
MX2015011394A
Other languages
English (en)
Inventor
Bill Potter
Original Assignee
Futura Medical Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Futura Medical Dev Ltd filed Critical Futura Medical Dev Ltd
Publication of MX2015011394A publication Critical patent/MX2015011394A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/02Contraceptive devices; Pessaries; Applicators therefor for use by males
    • A61F6/04Condoms, sheaths or the like, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se provee un condón que tiene un recubrimiento o depósito de una composición que incluye un agente fisiológicamente activo tal como gliceril trinitrato, donde el condón ha sido tratado con un material neutralizante o ácido de modo tal que el condón, cuando es sumergido en agua, logra que el agua tenga un pH de 7 o menos. El condón puede tratarse con una suspensión ácida de polvo para espolvoreo. Además se provee un proceso para la fabricación de condones, donde el proceso incluye las etapas de: 1) el tratamiento de los condones formados con un material neutralizante o ácido; y 2) a continuación, la aplicación a los condones, de una composición que incluye un agente fisiológicamente activo tal como gliceril trinitrato, donde los condones, cuando son sumergidos en agua, logran que el agua tenga un pH de 7 o menos.
MX2015011394A 2013-03-04 2014-03-04 Condon. MX2015011394A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1303796.5A GB201303796D0 (en) 2013-03-04 2013-03-04 Condom
PCT/GB2014/050629 WO2014135855A1 (en) 2013-03-04 2014-03-04 Condom

Publications (1)

Publication Number Publication Date
MX2015011394A true MX2015011394A (es) 2016-06-06

Family

ID=48142346

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011394A MX2015011394A (es) 2013-03-04 2014-03-04 Condon.

Country Status (14)

Country Link
US (1) US10004712B2 (es)
EP (1) EP2964191A1 (es)
JP (1) JP6337027B2 (es)
KR (1) KR20150138217A (es)
CN (1) CN105188665A (es)
AR (1) AR095020A1 (es)
AU (1) AU2014224449B2 (es)
BR (1) BR112015021306A2 (es)
CA (1) CA2903289A1 (es)
GB (1) GB201303796D0 (es)
MX (1) MX2015011394A (es)
RU (1) RU2668527C2 (es)
TW (1) TW201440747A (es)
WO (1) WO2014135855A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9904508B1 (en) * 2016-09-27 2018-02-27 Bose Corporation Method for changing type of streamed content for an audio system
CN110467741A (zh) 2018-04-20 2019-11-19 中科艾玛科技成都有限公司 一种亲水超滑的避孕套

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482053A (en) * 1989-06-06 1996-01-09 Kelly; Patrick D. Condom lubricants containing zinc as an anti-viral agent
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
JP2002165822A (ja) 2000-12-04 2002-06-11 Sagami Gomme Kogyo Kk 潤滑剤組成物及び同組成物を塗布したコンドーム(2)
EP1379203B1 (en) 2001-03-30 2006-03-01 Futura Medical Developments Limited Condom with an erectogenic composition
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
US20050076917A1 (en) * 2003-10-10 2005-04-14 Biofilm Ip, Llc. Lubricated condom
EP1576880A1 (en) * 2004-03-16 2005-09-21 Well-being Biochemical Corp. Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use
WO2006049627A1 (en) * 2004-11-02 2006-05-11 Biofilm Ip, Llc Lubricated condom
US20090197946A1 (en) * 2008-01-31 2009-08-06 Joseph Di Bartolomeo Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
US8087412B2 (en) * 2008-05-01 2012-01-03 Ansell Healthcare Products Llc Dip-formed synthetic polyisoprene latex articles with improved intraparticle and interparticle crosslinks
CN202619949U (zh) * 2011-10-19 2012-12-26 北京东方神起科技发展有限公司 一种ph值中性润滑层的安全套
WO2014020613A1 (en) * 2012-07-30 2014-02-06 Plantus Health Supplements Private Limited Probiotic layered condom
CN103405594A (zh) * 2013-05-30 2013-11-27 石杰克 水溶性人体润滑剂及其制备方法和采用该润滑剂的安全套

Also Published As

Publication number Publication date
CN105188665A (zh) 2015-12-23
RU2668527C2 (ru) 2018-10-01
CA2903289A1 (en) 2014-09-12
BR112015021306A2 (pt) 2017-07-18
EP2964191A1 (en) 2016-01-13
WO2014135855A1 (en) 2014-09-12
TW201440747A (zh) 2014-11-01
RU2015138950A (ru) 2017-04-07
JP2016511045A (ja) 2016-04-14
JP6337027B2 (ja) 2018-06-06
AU2014224449B2 (en) 2018-04-19
KR20150138217A (ko) 2015-12-09
AU2014224449A1 (en) 2015-09-24
AR095020A1 (es) 2015-09-16
US10004712B2 (en) 2018-06-26
GB201303796D0 (en) 2013-04-17
US20160015668A1 (en) 2016-01-21

Similar Documents

Publication Publication Date Title
MX2015014314A (es) Metodo de tratamiento de un sustrato animal.
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
MX2016014526A (es) Productos de consumo.
MX2017004304A (es) Metodo para tratar un sustrato animal.
GB2548234A (en) Weighted composition for treatment of a subterranean formation
MX2016000142A (es) Metodos mejorados de control de la corrosion.
MX2018012228A (es) Procedimiento mejorado para la fosfatacion libre de niquel de superficies metalicas.
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
PH12019550265A1 (en) Composition comprising mannose oligosaccharide and process for making same and use thereof
IL275182A (en) Preparations and methods for the treatment of metabolic conditions
AU2015279834A8 (en) Use of peptides that block metadherin-SND1 interaction as treatment for cancer
WO2015080581A3 (en) Biobased coating for iron comprising surfaces
GB2556735A (en) Weighted composition for treatment of a subterranean formation
HK1259017A1 (zh) 皮膜形成組合物和金屬材料的處理方法
SG11201807314YA (en) Method for manufacturing plasterboards
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
PH12018550008A1 (en) Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
IL272121A (en) Preparation and methods for the treatment of myopia
MX2015011394A (es) Condon.
WO2015075062A3 (en) Method of treating hair
IN2013MU02455A (es)
UA87159U (ru) Способ предпосевной обработки семян пшеницы
WO2014051983A3 (en) Treatment process, oxide-forming treatment composition, and treated component
RU2013104217A (ru) Способ имплантирования наноалмазных материалов комбинированной электромеханической обработкой (инмэмо)
MX2019004179A (es) Composiciones de apilimod y metodos para utilizar las mismas en el tratamiento de la enfermedad de alzheimer.